FBLG Stock Summary and Trading Ideas (Fibrobiologics | NASDAQ:FBLG)

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Fibrobiologics trades on the NASDAQ stock market under the symbol FBLG.

As of August 19, 2026, FBLG stock price climbed to $1.20 with 287,995 million shares trading.

FBLG has a beta of -0.30, meaning it tends to be less sensitive to market movements. FBLG has a correlation of 0.00 to the broad based SPY ETF.

FBLG has a market cap of $7.99 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that FBLG belongs to (by Net Assets): VXF.

FBLG has underperformed the market in the last year with a return of -90.3%, while SPY returned +21.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FBLG shares. However, FBLG has outperformed the market in the last 3 month and 2 week periods, returning +10.1% and +46.0%, while SPY returned +4.7% and 0.0%, respectively. This indicates FBLG has been having a stronger performance recently.

FBLG support price is $1.06 and resistance is $1.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBLG shares will trade within this expected range on the day.